Prestige Consumer [PBH] vs Zoetis [ZTS] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Prestige Consumer Healthcare Inc. wins in 9 metrics, Zoetis Inc. wins in 11 metrics, with 0 ties. Zoetis Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Prestige Consumer Healthcare Inc. | Zoetis Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 15.18 | 19.58 | Prestige Consumer Healthcare Inc. |
| Price-to-Book Ratio | 1.49 | 15.04 | Prestige Consumer Healthcare Inc. |
| Debt-to-Equity Ratio | 59.00 | 279.59 | Prestige Consumer Healthcare Inc. |
| PEG Ratio | -0.75 | 2.81 | Zoetis Inc. |
| EV/EBITDA | 10.24 | 13.96 | Prestige Consumer Healthcare Inc. |
| Profit Margin (TTM) | 16.90% | 28.24% | Zoetis Inc. |
| Operating Margin (TTM) | 29.10% | 34.69% | Zoetis Inc. |
| EBITDA Margin (TTM) | 29.10% | 34.69% | Zoetis Inc. |
| Return on Equity | 10.31% | 65.99% | Zoetis Inc. |
| Return on Assets (TTM) | 6.13% | 15.26% | Zoetis Inc. |
| Free Cash Flow (TTM) | $243.29M | $2.28B | Zoetis Inc. |
| Dividend Yield | N/A | 1.21% | N/A |
| 1-Year Return | -44.52% | -53.93% | Prestige Consumer Healthcare Inc. |
| Price-to-Sales Ratio (TTM) | 2.51 | 5.26 | Prestige Consumer Healthcare Inc. |
| Enterprise Value | $3.74B | $56.75B | Zoetis Inc. |
| EV/Revenue Ratio | 3.39 | 6.00 | Prestige Consumer Healthcare Inc. |
| Gross Profit Margin (TTM) | 55.52% | 70.17% | Zoetis Inc. |
| Revenue per Share (TTM) | $23 | $21 | Prestige Consumer Healthcare Inc. |
| Earnings per Share (Diluted) | $3.79 | $6.02 | Zoetis Inc. |
| Beta (Stock Volatility) | 0.47 | 0.97 | Prestige Consumer Healthcare Inc. |
| Short % of Float | 8.04% | 4.06% | Zoetis Inc. |
Prestige Consumer Healthcare Inc. vs Zoetis Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | -0.85% | -4.56% | -17.14% | -33.12% | -23.22% | -25.14% |
| Zoetis Inc. | 1.51% | -4.46% | -31.75% | -39.76% | -38.95% | -38.30% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | -44.52% | -18.75% | -4.94% | -11.39% | 281.46% | 345.87% |
| Zoetis Inc. | -53.93% | -54.80% | -55.66% | 62.09% | 150.53% | 150.53% |
Performance & Financial Health Analysis: Prestige Consumer Healthcare Inc. vs Zoetis Inc.
| Metric | PBH | ZTS |
|---|---|---|
| Market Information | ||
| Market Cap | $2.78B | $49.75B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 403,677 | 2,727,710 |
| 90 Day Avg. Volume | 517,876 | 3,835,940 |
| Last Close | $45.44 | $167.10 |
| 52 Week Range | $42.62 - $87.12 | $139.70 - $200.33 |
| % from 52W High | -47.84% | -16.59% |
| All-Time High | $90.04 (Mar 10, 2025) | $249.27 (Dec 27, 2021) |
| % from All-Time High | -49.53% | -32.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | 0.03% |
| Quarterly Earnings Growth | -0.24% | 0.04% |
| Financial Health | ||
| Profit Margin (TTM) | 0.17% | 0.28% |
| Operating Margin (TTM) | 0.29% | 0.35% |
| Return on Equity (TTM) | 0.10% | 0.66% |
| Debt to Equity (MRQ) | 59.00 | 279.59 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $38.66 | $7.84 |
| Cash per Share (MRQ) | $1.32 | $5.48 |
| Operating Cash Flow (TTM) | $276.63M | $2.90B |
| Levered Free Cash Flow (TTM) | $207.17M | $1.79B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.21% |
| Last 12-Month Dividend | $0.00 | $2.03 |
Valuation & Enterprise Metrics Analysis: Prestige Consumer Healthcare Inc. vs Zoetis Inc.
| Metric | PBH (Apr 24, 2026) | ZTS (Apr 13, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 15.18 | 19.58 |
| Forward P/E | 11.96 | 15.61 |
| PEG Ratio | -0.75 | 2.81 |
| Price to Sales (TTM) | 2.51 | 5.26 |
| Price to Book (MRQ) | 1.49 | 15.04 |
| Market Capitalization | ||
| Market Capitalization | $2.78B | $49.75B |
| Enterprise Value | $3.74B | $56.75B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.39 | 6.00 |
| Enterprise to EBITDA | 10.24 | 13.96 |
| Risk & Other Metrics | ||
| Beta | 0.47 | 0.97 |
| Book Value per Share (MRQ) | $38.66 | $7.84 |
Financial Statements Comparison: Prestige Consumer Healthcare Inc. vs Zoetis Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | PBH (2025) | ZTS (2025) |
|---|---|---|
| Revenue/Sales | 1.14B | 9.47B |
| Cost of Goods Sold | 503.30M | 2.67B |
| COGS % of Revenue | 44.2% | 28.2% |
| Gross Profit | 634.46M | 6.80B |
| Gross Margin | 55.8% | 71.8% |
| Research & Development | N/A | 698.00M |
| Operating Income (EBIT) | 349.24M | 3.60B |
| Operating Margin | 30.7% | 38.0% |
| EBITDA | 374.46M | 4.17B |
| EBITDA Margin | 32.9% | 44.1% |
| Pre-Tax Income | 284.19M | 3.36B |
| Pre-Tax Income % of Revenue | 25.0% | 35.5% |
| Income Tax | 69.58M | 687.00M |
| Income Tax % of Revenue | 6.1% | 7.3% |
| Net Income (Profit) | 214.61M | 2.67B |
| Profit Margin | 18.9% | 28.2% |
Balance Sheet & Liquidity Metrics
| Metric | PBH (2025) | ZTS (2025) |
|---|---|---|
| Cash & Equivalents | 97.88M | 2.31B |
| Total Current Assets | 448.33M | 6.77B |
| Total Current Assets % of Revenue | 39.4% | 71.5% |
| Total Current Liabilities | 106.62M | 2.24B |
| Total Current Liabilities % of Revenue | 9.4% | 23.6% |
| Long-Term Debt | 1.04B | 9.24B |
| Long-Term Debt % of Revenue | 91.0% | 97.6% |
| Total Shareholders Equity | 1.83B | 3.33B |
| Retained Earnings | 1.56B | 13.74B |
| Retained Earnings % of Revenue | 136.7% | 145.2% |
| Property, Plant & Equipment | 53.29M | 288.00M |
Cash Flow Statement Comparison
| Metric | PBH (2025) | ZTS (2025) |
|---|---|---|
| Operating Cash Flow | 227.18M | 2.78B |
| Operating Cash Flow % of Revenue | 20.0% | 29.3% |
| Capital Expenditures | -8.22M | N/A |
| Free Cash Flow | 243.29M | 2.28B |
| FCF Margin | 21.4% | 24.1% |
| Debt Repayment | -139.54M | -1.35B |
| Common Stock Repurchase | -51.51M | -3.24B |
Short Interest & Institutional Ownership Analysis
| Metric | PBH | ZTS |
|---|---|---|
| Shares Short | 2.69M | 15.12M |
| Short Ratio | 5.78 | 3.60 |
| Short % of Float | 8.04% | 4.06% |
| Shares Outstanding | 47.32M | 424.93M |
| Float Shares | 46.75M | 421.29M |
| % Held by Insiders | 1.30% | 0.15% |
| % Held by Institutions | 111.41% | 101.50% |
| % Held by Public | -12.71% | -1.65% |
Dividend Analysis & Yield Comparison: Prestige Consumer Healthcare Inc. vs Zoetis Inc.
| Metric | PBH | ZTS |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $2.03 |
| Last 12-Month Dividend Yield | N/A | 1.21% |
| 3-Year Avg Annual Dividend | $0.00 | $1.80 |
| 3-Year Avg Dividend Yield | N/A | 0.29% |
| 3-Year Total Dividends | $0.00 | $5.39 |
| Ex-Dividend Date | N/A | Jan 20, 2026 |